Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May;99(5):804-805.
doi: 10.1002/ajh.27292. Epub 2024 Mar 14.

JAK inhibitor treatment-resistant splenomegaly before transplantation in myelofibrosis: Splenectomy or radiotherapy?

Affiliations
Free article
Editorial

JAK inhibitor treatment-resistant splenomegaly before transplantation in myelofibrosis: Splenectomy or radiotherapy?

Maria Chiara Finazzi et al. Am J Hematol. 2024 May.
Free article
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Gagelmann N, Hobbs GS, Campodonico E, et al. Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: a global collaborative analysis. Am J Hematol. 2024;99(5):844‐853. doi:10.1002/ajh.27252
    1. Kröger N, Wolschke C, Gagelmann N. How I treat transplant‐eligible patients with myelofibrosis. Blood. 2023;142(20):1683‐1696. doi:10.1182/blood.2023021218
    1. Alchalby H, Yunus DR, Zabelina T, Ayuk F, Kröger N. Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis. Bone Marrow Transplant. 2016;51(9):1223‐1227. doi:10.1038/bmt.2016.98
    1. Akpek G, Pasquini MC, Logan B, et al. Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48(6):825‐831. doi:10.1038/bmt.2012.249
    1. Kröger N, Sbianchi G, Sirait T, et al. Impact of prior JAK‐inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT. Leukemia. 2021;35(12):3551‐3560. doi:10.1038/s41375‐021‐01276‐4

Substances

LinkOut - more resources